Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
American Cancer Society, National Institutes of Health, and Hope Foundation for Cancer Research.
Publications
5 shownNivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
First-line treatment with nivolumab plus ipilimumab resulted in a longer duration of overall survival than did chemotherapy in patients with NSCLC, independent of the PD-L1 expr...
Frequent Co-Authors
Researcher Info
- h-index
- 5
- Publications
- 5
- Citations
- 11,497
- Institution
- University Hospital of Lausanne
External Links
Identifiers
- ORCID
- 0000-0002-0412-7143
Impact Metrics
h-index
5
h-index: Number of publications with at least h citations each.